Medical Cannabidiol Act Implementation

• Future Meeting Dates

  • TBD
• November 6, 2026: MCB Meeting
  • November 6, 2026: MCB Agenda
  • March 27, 2026: MCB Minutes
    Carl Olsen: Mr. Olsen discussed federal marijuana rescheduling, the separate federal rulemaking pathways, and pending litigation.  He asked the Board to continue recommending a legal task force to explore a federal exemption under 21 U.S.C. § 822(d).
  • November 6, 2026: MCB Update
  • November 6, 2026: Carl Olsen Public Comment
• July 24, 2026: Audio Recording
• July 24, 2026: MCB Meeting
  • July 24, 2026: MCB Agenda
  • March 27, 2026: MCB Minutes
    Carl Olsen: Mr. Olsen expressed support for the Board’s previous recommendations regarding a federal exemption under 21 U.S.C. § 822(d) and encouraged continued consideration of those recommendations.  He also noted his efforts to share the Board’s recommendations with state and federal policymakers.
  • July 24, 2026: MCB Update
  • July 24, 2026: Carl Olsen Public Comment
• March 27, 2026: Audio Recording
• March 27, 2026: MCB Meeting
  • March 27, 2026: MCB Agenda
  • November 14, 2025: MCB Minutes
    Carl Olsen: Carl shared that President Trump signed legislation that will essentially shut down the consumable hemp program, and he suspects it is a segue into rescheduling cannabis to schedule III.  He stated that a schedule III classification does not make the program legal, and encouraged the board to continue to have the recommendation of applying for a federal waiver as part of the annual report.
• January 1, 2026: 2025 Annual Report to the General Assembly